{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:22:47Z","timestamp":1792498967255,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.redox.2025.103641","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T02:45:24Z","timestamp":1744685124000},"page":"103641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cth\/Mpst double ablation results in early onset fatty liver disease in lean mice"],"prefix":"10.1016","volume":"83","author":[{"given":"Antonia","family":"Katsouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Markou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Valakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Theodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-5930","authenticated-orcid":false,"given":"Andreas","family":"Papapetropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2025.103641_bib1","first-page":"328","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver","volume":"67","author":"Chalasani","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.redox.2025.103641_bib2","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/bph.17458","article-title":"Novel drugs approved by the EMA, the FDA and the MHRA in 2024: a year in review","volume":"182","author":"Topouzis","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2025.103641_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.redox.2025.103641_bib4","doi-asserted-by":"crossref","unstructured":"A. Afshin, M.H. Forouzanfar, M. Reitsma, P. Sur, K. Estep, A. Lee, L. Marczak, A.H. Mokdad, M. Moradi-Lakeh, Health Effects of Overweight and Obesity in 195 Countries over 25 Years. GBD 2015 Obesity Collaborators, N. Engl. J. Med. 377 (n.d.) 13\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1614362.","DOI":"10.1056\/NEJMoa1614362"},{"key":"10.1016\/j.redox.2025.103641_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.redox.2025.103641_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2025.103641_bib7","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1152\/ajpendo.00294.2015","article-title":"Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway","volume":"309","author":"Sun","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.redox.2025.103641_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117661","article-title":"Cystathionine gamma-lyase\/H2S system suppresses hepatic acetyl-CoA accumulation and nonalcoholic fatty liver disease in mice","volume":"252","author":"Ali","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2025.103641_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1152\/physrev.00028.2021","article-title":"Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs","volume":"103","author":"Cirino","year":"2023","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.redox.2025.103641_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/ars.2013.5339","article-title":"Enzymology of H2S biogenesis, decay and signaling","volume":"20","author":"Kabil","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2025.103641_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/ars.2013.5309","article-title":"Production and physiological effects of hydrogen sulfide","volume":"20","author":"Kimura","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2025.103641_bib12","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/hep.32577","article-title":"Hepatocellular cystathionine \u03b3 lyase\/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor","volume":"76","author":"Xu","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2025.103641_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11434-014-0722-7","article-title":"Deficiency of cystathionine gamma-lyase and hepatic cholesterol accumulation during mouse fatty liver development","volume":"60","author":"Mani","year":"2015","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.redox.2025.103641_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211894","article-title":"MPST sulfurtransferase maintains mitochondrial protein import and cellular bioenergetics to attenuate obesity","volume":"219","author":"Katsouda","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.redox.2025.103641_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1090654","article-title":"CTH\/MPST double ablation results in enhanced vasorelaxation and reduced blood pressure via upregulation of the eNOS\/sGC pathway","volume":"14","author":"Katsouda","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2025.103641_bib16","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2382","article-title":"Endpoint or kinetic measurement of hydrogen sulfide production capacity in tissue extracts","volume":"7","author":"Hine","year":"2017","journal-title":"Bio Protoc"},{"key":"10.1016\/j.redox.2025.103641_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2014.11.048","article-title":"Endogenous hydrogen sulfide production is essential for dietary restriction benefits","volume":"160","author":"Hine","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.redox.2025.103641_bib18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2025.103641_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166085","article-title":"The role of the retinoid receptor, RAR\/RXR heterodimer, in liver physiology","volume":"1867","author":"Li","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.redox.2025.103641_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.redox.2025.103641_bib21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.redox.2025.103641_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.redox.2025.103641_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.livres.2023.07.002","article-title":"Retinoic acid signaling in fatty liver disease","volume":"7","author":"Cassim Bawa","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.redox.2025.103641_bib24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103641_bib25","first-page":"73","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence","volume":"64","author":"Younossi","year":"2015","journal-title":"Incidence, and Outcomes"},{"key":"10.1016\/j.redox.2025.103641_bib26","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/srep01986","article-title":"Antioxidant enzyme, 3-mercaptopyruvate sulfurtransferase-knockout mice exhibit increased anxiety-like behaviors: a model for human mercaptolactate- cysteine disulfiduria","volume":"3","author":"Nagahara","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2025.103641_bib27","first-page":"4212","article-title":"Cystathionine \u03b3-lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.redox.2025.103641_bib28","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2025.103641_bib29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI118951","article-title":"Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a","volume":"98","author":"Shimano","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2025.103641_bib30","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI119248","article-title":"Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells","volume":"99","author":"Shimano","year":"1997","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2025.103641_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103641_bib32","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta","volume":"14","author":"Repa","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.redox.2025.103641_bib33","article-title":"The dual role of Nrf2 in nonalcoholic fatty liver disease: regulation of antioxidant defenses and hepatic lipid metabolism","volume":"18","author":"Chambel","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.redox.2025.103641_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.redox.2025.103641_bib35","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher's guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.redox.2025.103641_bib36","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.redox.2025.103641_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","article-title":"Preclinical models of non-alcoholic fatty liver disease","volume":"68","author":"Santhekadur","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103641_bib38","first-page":"108","volume":"vol. 61","author":"Smagris","year":"2014"},{"key":"10.1016\/j.redox.2025.103641_bib39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep4.1381","article-title":"Liver proliferation is an essential driver of fibrosis in mouse models of nonalcoholic fatty liver disease","volume":"3","author":"Cast","year":"2019","journal-title":"Hepatol Commun"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725001545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725001545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:22:14Z","timestamp":1762608134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725001545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"alternative-id":["S2213231725001545"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103641","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cth\/Mpst double ablation results in early onset fatty liver disease in lean mice","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103641"}}